Prodrugs of benzoquinolizine-2-carboxylic acid
    3.
    发明授权
    Prodrugs of benzoquinolizine-2-carboxylic acid 有权
    苯喹啉-2-羧酸的前药

    公开(公告)号:US07868173B2

    公开(公告)日:2011-01-11

    申请号:US11715921

    申请日:2007-03-09

    IPC分类号: C07D221/06 A61K31/473

    CPC分类号: C07D455/04

    摘要: The instant invention relates to novel prodrugs of optically pure benzoquinolizine-2-carboxylic acid and pharmaceutical compositions that include the prodrugs. In particular, the present invention relates to the sulfonic acid salts of L-alanine and L-valine prodrugs of S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid. The compounds and compositions of the invention can be used to treat bacterial Gram-positive, Gram-negative and anaerobic infections, especially infections caused by resistant Gram-positive organism and Gram-negative organism, mycobacterial infections and emerging nosocomial pathogen infections.

    摘要翻译: 本发明涉及光学纯苯醌喹唑啉-2-羧酸的新型前体药物和包含前药的药物组合物。 特别地,本发明涉及L-丙氨酸的磺酸盐和S - ( - ) - 9-氟-6,7-二氢-8-(4-羟基哌啶-1-基) - 5-甲基-1-氧代-1H,5H-苯并[i,j]喹嗪-2羧酸。 本发明的化合物和组合物可用于治疗细菌革兰氏阳性,革兰氏阴性和厌氧感染,特别是由抗性革兰氏阳性生物和革兰氏阴性生物,分枝杆菌感染和新出现的医院病原体感染引起的感染。